BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Senator calls on Biden to reject COVID IP waiver

2 March 2021 Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation.

Big Pharma

Quercis licenses patents for thromboembolism platform

28 January 2021 Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer.

Big Pharma

South Africa, India urge WTO to waive IP for COVID-19 treatments

8 October 2020 South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.

More on this story

Medtech

Senator calls on Biden to reject COVID IP waiver

Big Pharma

Quercis licenses patents for thromboembolism platform

28 January 2021 Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer.

Big Pharma

South Africa, India urge WTO to waive IP for COVID-19 treatments

More on this story

Medtech

Senator calls on Biden to reject COVID IP waiver

Big Pharma

Quercis licenses patents for thromboembolism platform

28 January 2021 Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer.

Big Pharma

South Africa, India urge WTO to waive IP for COVID-19 treatments